No Data
No Data
Toyokumo, Kaiomu, and others [Emerging Markets Press Release]
<3224> Dissolution of agreement between G Oyster Nexta (Nexta anonymous association operator) <4058> Tokumoto additional public offering, 0.12 million shares <4576> DWTI 12th subscription rights (with exercise price adjustment clause) Large-scale exercise of 1.75 million shares of shares to be delivered from the 20th <4583> Asahi Kasei Pharma, engaging in business in the field of pharmaceuticals and diagnostic drugs, signs exclusive license agreement with anti-CX3CR1 antibody <5247> Establishes a subsidiary of BTM, <6573
General Oyster: Extraordinary Report
General Oyster 1H Loss Y23.00M Vs Loss Y14.00M
General Oyster: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
General Oyster: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)
General Oyster: Confirmatory letter.
No Data
No Data